Endo Pharmaceuticals Should Thrive As Boomers Age

Posted on June 24, 2009
Filed Under Friends, History, Investing |

Another drug stock that I really like is Endo Pharmaceuticals (ENDP) . Endo Pharmaceuticals is a midcap biotechnology company that is know for developing and selling pain management drugs and therapies. This company may be a good investment as a play on an aging baby boomer population. The generic pharmaceutical market is a highly profitable market as drug patents expire from bigger name players. Endo also has a strong drug development division along with established money makers Percocet, Perc

Read more:
Endo Pharmaceuticals Should Thrive As Boomers Age

Comments